NPM1 Is a Prognostic Biomarker Involved in Immune Infiltration of Lung Adenocarcinoma and Associated With m6A Modification and Glycolysis - Concepedia

Concepedia

Publication | Open Access

NPM1 Is a Prognostic Biomarker Involved in Immune Infiltration of Lung Adenocarcinoma and Associated With m6A Modification and Glycolysis

DOI Full Paper Access

129

Citations

44

References

2021

Year

Xu‐Sheng Liu, Lu-Meng Zhou, Lingling Yuan, Yan Gao, Xue-Yan Kui, Xiaoyu Liu, Zhi‐Jun Pei

Frontiers in Immunology

Abstract

NPM1 is a prognostic biomarker involved in immune infiltration of LUAD and associated with m6A modification and glycolysis. NPM1 can be used as an effective target for diagnosis and treatment of LUAD.

References

	Year	Citations

Page 1